Medication info
Tamidol Semi Tablet

Tamidol Semi Tablet

Prescription medicationTabletOral
Ingredient · strength
Acetaminophen›162.5mg / 1 tabletTramadol Hydrochloride›18.75mg / 1 tablet
Manufacturer / importer
Hawon Pharmaceutical Co., Ltd.
Appearance
Light yellow oblong film-coated tablet
Packaging
30 tablets/bottle, 300 tablets/bottle
Approval status
Active

MFDS item code 200712789 · Notified 2007.11.23 · Insurance code 651502520

Summary

Main use
Relief of moderate to severe acute and chronic pain
Who takes it
Adults · Children
Adult dose
Elderly patients Administer the usual adult dose. However, because the elimination half-life of tramadol increased by 17% when administered orally to patients 75 years of age and older, administer this medicine at intervals of at least 6 hours. Patients with renal impairment For patients with moderate renal impairment (creatinine clearance 10-30ml/min), extend the dosing interval to 12 hours. Use is not recommended in patients with severe renal impairment (creatinine clearance less than 10ml/min). Because tramadol is removed very slowly during hemodialysis and filtration, readministration of this medicine is not necessary to maintain analgesia after dialysis. Patients with hepatic impairment Carefully consider extending the dosing interval in patients with moderate hepatic impairment. Do not administer this medicine to patients with severe hepatic impairment.
Child dose
Children 12 years of age and older: An initial dose of 4 tablets is recommended. Thereafter, leave an interval of at least 6 hours between doses and do not exceed 16 tablets per day.

Ingredients

Manufacturer
Hawon Pharmaceutical Co., Ltd.

Efficacy & effects

Relief of moderate to severe acute and chronic pain

  • Moderate to severe acute pain
  • chronic pain
View approved original text

This medication is used to relieve moderate to severe acute and chronic pain.

How to take

Adult dose

Elderly patients Administer the usual adult dose. However, because the elimination half-life of tramadol increased by 17% when administered orally to patients 75 years of age and older, administer this medicine at intervals of at least 6 hours. Patients with renal impairment For patients with moderate renal impairment (creatinine clearance 10-30ml/min), extend the dosing interval to 12 hours. Use is not recommended in patients with severe renal impairment (creatinine clearance less than 10ml/min). Because tramadol is removed very slowly during hemodialysis and filtration, readministration of this medicine is not necessary to maintain analgesia after dialysis. Patients with hepatic impairment Carefully consider extending the dosing interval in patients with moderate hepatic impairment. Do not administer this medicine to patients with severe hepatic impairment.

Child dose

Children 12 years of age and older: An initial dose of 4 tablets is recommended. Thereafter, leave an interval of at least 6 hours between doses and do not exceed 16 tablets per day.

Precautions

This medication may put stress on the liver, so those who consume large amounts of alcohol daily should consult a doctor or pharmacist before taking it. The ingredients in this medication can infrequently cause serious allergic reactions on the skin, so if a skin rash or hypersensitivity occurs, stop taking it immediately and seek medical attention. Due to the risk of seizures, caution is especially needed when taking it with a history of seizures or certain antidepressants and narcotic analgesics. There is a risk of respiratory depression, so individuals with severe asthma or respiratory issues should use this medication under medical supervision. When taken with central nervous system depressants or alcohol, this medication can cause severe sedation, respiratory depression, or coma, so it should be avoided or monitored closely. In cases of head injury or brain disease, caution is warranted as the respiratory depression effect may exacerbate symptoms. This medication can cause psychological and physical dependence, so appropriate dosages and duration should be followed as directed by a doctor during long-term use. Patients with impaired liver function must consult a doctor before taking this medication and should avoid taking it with other acetaminophen-containing drugs. Patients with certain genetic metabolic types may metabolize this medication rapidly, increasing the risk of respiratory depression, and should be closely monitored. Children under 12 years old, and adolescents under 18 years old who have undergone tonsillectomy or adenoidectomy, should not take this medication. Adolescents aged 12 to 18 should avoid it if there are specific risk factors. This medication may cause sleep apnea or hypoxia, so continuous observation for symptom appearance or worsening is necessary, considering dosage adjustment or discontinuation if needed. Elderly patients or those with impaired kidney or liver function should use this medication with greater caution, as the likelihood of adverse reactions is higher, requiring careful monitoring. Pregnant women or those who may become pregnant should carefully consider the benefits and risks of using this medication due to potential effects on the fetus. Breastfeeding women should ideally not take this medication, as it can pass into breast milk and cause serious side effects in infants; caution is necessary. This medication may cause drowsiness or dizziness, so caution is required when performing hazardous tasks such as driving or operating machinery. In the event of overdose, serious respiratory depression, seizures, or liver damage may occur, so immediate emergency treatment is necessary, and care should be taken not to exceed the prescribed dose. During the course of this medication, avoid concomitant use with other analgesics or central nervous system depressants, always considering the possibility of drug interactions. This medication should be stored out of reach of children, and careful management is required to prevent misuse or abuse.

Side effects

Liver damage, acute widespread pustular rash, Stevens-Johnson syndrome, toxic epidermal necrolysis, seizures, anaphylactic reaction, respiratory depression, deep sedation, coma, death, carbon dioxide retention, psychological dependence, physical dependence, hyponatremia, appetite loss, insomnia, depression, dizziness, headache, drowsiness, nausea, vomiting, constipation, dry mouth, diarrhea, dyspepsia, abdominal pain, abdominal discomfort, flatulence, pruritus, sweating, rash, fatigue, flushing, urticaria, hypersensitivity, hypoglycemia, anxiety, nervous hyperactivity, emotional instability, euphoria, decreased libido, sleep disorders, confusion, spatial disorientation, agitation, abnormal dreams, drug abuse, hallucinations, withdrawal syndrome, migraine, hypersomnia, sensory下降, tremor, sensory abnormalities, attention disorder, syncope, memory impairment, psychomotor agitation, sedation, amnesia, perceptual disturbances, seizures, blurred vision, visual impairment, pupil constriction, dizziness, tinnitus, ear discomfort, palpitations, tachycardia, hypertension, hypotension, dyspnea, dry throat, elevated liver enzymes, generalized pruritus, sweating, urinary disorders, erectile dysfunction, asthenia, chest pain, emotional abnormalities, chills, chest discomfort, apathy, drug withdrawal syndrome, thirst, irritability, warmth sensation, weight loss, increased serum creatinine, anaphylaxis reaction, emotional instability, delirium, suicidal thoughts, muscle hypertonia, movement disorders, serotonin syndrome, speech disorders, mydriasis, orthostatic hypotension, hepatitis, gait disturbances, prolonged prothrombin time, fixed rash, asthenia, fever, edema, rigidity, syncope, congestive heart failure, confusion, exacerbation of migraine, involuntary muscle contractions, exertional dyspnea, cough, bronchitis, urinary retention, frequent urination, abnormal kidney function tests, oliguria, increased sweating, dysphagia, tongue swelling, increased salivation, progression of rectal cancer, progression of esophageal cancer, progression of gastric cancer, paralytic ileus, hiccups, cholecystitis, appetite suppression, panic attacks, rigidity, pain, upper respiratory tract syndrome, hirsutism, hyperactivity, toxic skin necrosis, bronchospasm, allergic reactions, severe anxiety, hallucinations, tinnitus, abnormal central nervous system reactions, severe respiratory depression, QT prolongation, myocardial infarction, liver failure, coagulopathy, hypotension, extreme fatigue, weight loss, withdrawal symptoms, opioid-induced hyperalgesia, adrenal insufficiency symptoms, hemorrhage, elevated cholesterol, tinnitus, chills, hip pain, thigh pain, allergic rhinitis, nasal bleeding, abnormal vision, progression of bile duct cancer, foreign body sensation in the eye, progression of liver cancer, liver function abnormalities

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a closed container to prevent air or moisture from entering. It is important to maintain a storage temperature between 1 and 30 degrees Celsius at room temperature to preserve the medication's effectiveness.

Appearance and packaging

Appearance

Light yellow oblong film-coated tablet

Package unit

30 tablets/bottle, 300 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.